中文摘要
在过去十年中,TIL(肿瘤浸润淋巴细胞)(TILs)已被认为是与改善生存相关的临床相关预后标志物,为开发新的治疗策略提供了免疫学基础,并在包括卵巢癌(OC)在内的多种恶性肿瘤中显示出显著的预后和预测作用。事实上,许多OC显示出TILs,其类型和浸润程度已被证明与预后和生存强烈相关。TILs存在率较高的OC组织学亚型是高级别浆液性癌(HGSC),其次是子宫内膜样亚型,而黏液性和透明细胞OC似乎含有较低比例的TILs。OC中TILs的大量存在提示该肿瘤具有免疫原性潜力。尽管具有高免疫原性潜力,OC被描述为高度免疫抑制性肿瘤,其TILs高表达PD1。尽管需要进一步研究以更好地确定其在预后分层和治疗意义中的作用,但上皮内TILs代表了OC中需要考虑的相关预后因素。在这篇综述中,我们将讨论TILs作为能够反映抗癌免疫反应的标志物的有前景的作用,描述其预测OC预后和治疗反应的潜在能力。
展开英文摘要原文
In the last decade, tumor-infiltrating lymphocytes (TILs) have been recognized as clinically relevant prognostic markers for improved survival, providing the immunological basis for the development of new therapeutic strategies and showing a significant prognostic and predictive role in several malignancies, including ovarian cancer (OC). In fact, many OCs show TILs whose typology and degree of infiltration have been shown to be strongly correlated with prognosis and survival. The OC histological subtype with the higher presence of TILs is the high-grade serous carcinoma (HGSC) followed by the endometrioid subtype, whereas mucinous and clear cell OCs seem to contain a lower percentage of TILs.
The abundant presence of TILs in OC suggests an immunogenic potential for this tumor. Despite the high immunogenic potential, OC has been described as a highly immunosuppressive tumor with a high expression of PD1 by TILs.
Although further studies are needed to better define their role in prognostic stratification and the therapeutic implication, intraepithelial TILs represent a relevant prognostic factor to take into account in OC. In this review, we will discuss the promising role of TILs as markers which are able to reflect the anticancer immune response, describing their potential capability to predict prognosis and therapy response in OC.
论文信息
- 作者
- Fanale D、Dimino A、Pedone E、Brando C、Corsini LR、Filorizzo C、Fiorino A、Lisanti MC
- 第一作者单位
- Section of Medical Oncology, Department of Surgical, Oncological and Oral Sciences, University of Palermo, 90127 Palermo, Italy.Italy
- 通讯作者单位
- Department of Biomedicine, Neuroscience and Advanced Diagnostics, University of Palermo, 90127 Palermo, Italy.Italy
- 文献类型
- 综述
- 期刊
- Cancers2022 Sep 6